ClinicalTrials.Veeva

Menu

Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty

MedStar Health logo

MedStar Health

Status

Terminated

Conditions

Osteoarthritis of the Knee
Neuralgia

Treatments

Procedure: Total knee arthroplasty with Saphenous nerve burial
Procedure: Standard total knee arthroplasty

Study type

Interventional

Funder types

Other

Identifiers

NCT02885467
IRB 2013-281

Details and patient eligibility

About

This is a randomized study investigating whether identification, ligation, and burial of superficial branches of the saphenous nerve crossing the surgical field during total knee arthroplasty reduces the rate of post-operative anterior knee pain and neuralgia compared to standard total knee arthroplasty.

Full description

Anterior knee pain is common after total knee arthroplasty. The incision necessarily travels through the path of a cutaneous nerve - branches of the saphenous nerve. Historically, no effort has been made to separate these branches and bury them away from the surgical scar. It has been noted that some patients develop a painful neuroma, that once resected results in a pain free knee. Investigators are trying to study if identification, ligation, and proper burial of the nerve can prevent the development of neuralgia compared to the typical surgical approach which ignores the nerve branches completely.

Enrollment

58 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must have symptomatic knee osteoarthritis under consideration for total knee arthroplasty
  • Must be willing to undergo randomization

Exclusion criteria

  • Age <18 or >80 years
  • Known pre-operative diagnosis of neuralgia, complex regional pain syndrome, or neuropathy, about the operative lower extremity
  • Known pre-operative psychiatric disorder requiring medication
  • Previous surgery about the operative knee
  • BMI > 40 kg/m2 (potential increased risk of soft tissue dissection through adipose)
  • Ongoing pre-operative narcotic use in excess of 20 mg morphine equivalents per day for at least one month or pre-operative intravenous drug use (increased potential for complex regional pain syndrome and neuralgia, increased likelihood to require greater post-operative analgesia)
  • Ongoing pre-operative use of neuropathic pain medications (gabapentin, pregabalin, amitriptyline, etc.)
  • Medical comorbidities (American Society of Anesthesiologists grade > 3 or deemed unfit by consulting internist) precluding elective TKA
  • Significant language barrier (reading comprehension less than 8th grade reading level) or mental condition precluding accurate self-assessment of knee pain or function.
  • Severe medication allergies to permissible post-operative analgesics (acetaminophen, tramadol, oxycodone, oxycontin, dilaudid)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

58 participants in 2 patient groups

Control
Active Comparator group
Description:
Standard total knee arthroplasty performed through medial parapatellar approach
Treatment:
Procedure: Standard total knee arthroplasty
Intervention
Experimental group
Description:
Total knee arthroplasty performed through medial parapatellar approach with identification, ligation, and burial of saphenous nerve branches
Treatment:
Procedure: Total knee arthroplasty with Saphenous nerve burial

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems